An update on the toxicity of cyanogenic glycosides bioactive compounds: Possible clinical application in targeted cancer therapy
- 20 February 2020
- journal article
- research article
- Published by Elsevier BV in Materials Chemistry and Physics
- Vol. 246, 122841
- https://doi.org/10.1016/j.matchemphys.2020.122841
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences
- Tabriz University of Medical Sciences (61976)
This publication has 67 references indexed in Scilit:
- Flavonoid glycosides and pharmacological activity of Amphilophium paniculatumPharmacognosy Research, 2013
- Anticancer activity of cardiac glycosidesOncoImmunology, 2012
- Viral and nonviral delivery systems for gene deliveryAdvanced Biomedical Research, 2012
- Redox Regulation of Cell SurvivalAntioxidants and Redox Signaling, 2008
- BNIP3 Is an RB/E2F Target Gene Required for Hypoxia-Induced AutophagyMolecular and Cellular Biology, 2007
- Cytotoxicity of purified cassava linamarin to a selected cancer cell linesBioprocess and Biosystems Engineering, 2007
- Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3Oncogene, 2004
- Preformed Antimicrobial Compounds and Plant Defense against Fungal AttackTHE PLANT CELL ONLINE, 1996
- LINAMARIN: THE TOXIC COMPOUND OF CASSAVAJournal of Venomous Animals and Toxins including Tropical Diseases, 1996
- On the metabolism of amygdalin. 1. The LD50 and biochemical changes in ratsCanadian Journal of Physiology and Pharmacology, 1985